DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersEvaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"Dominant Negative ATM Mutations in Breast Cancer FamiliesMost germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evidentMutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndromeGenome-wide association studies identify four ER negative-specific breast cancer risk lociNcoI RFLP of the human LHRH gene on chromosome 8pEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerGenome-wide association study identifies novel breast cancer susceptibility lociPolymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersAnalysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancerThe androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriersNo evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancerThe intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in AustraliaNo germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancerCYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphismsNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskAssociation between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.Mutations of the BRAF gene in human cancerAssignment of the human slit homologue SLIT2 to human chromosome band 4p15.2Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancerFine genetic mapping of the gene for nevoid basal cell carcinoma syndromeLocalization of the gene for human proliferating nuclear antigen/cyclin by in situ hybridizationLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairReduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomasGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Common variants at 19p13 are associated with susceptibility to ovarian cancer.Patterns of somatic mutation in human cancer genomesGenetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentIntegration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
P50
Q21144874-702E9153-1065-4875-A044-3D51AD38C722Q21144976-BCB9DD13-6B19-43C2-8D54-84E0BF77C54CQ22066027-24247FB9-FC62-475D-AE46-3F42B86C1F2BQ24310445-C5C5F813-A695-466B-ADC2-F14716AC06DAQ24336457-FA3CCE12-26A9-4125-91B4-D0FFE4E73D80Q24622610-066CE75F-27A6-44FC-9200-3CF06647ADFBQ24629025-1D6B40E9-E255-4987-9EFE-18EADE501DBFQ24633316-D3846715-8702-4946-AC57-84B5A61BB997Q24645441-E4E66601-2D26-49A9-9A4B-E962020B939CQ24648412-80981218-4BB2-4CFF-9DD0-ADB0755630DCQ24655824-39FD42B8-59BF-4D50-BA38-E630BAA9CF6AQ24656704-D919EE83-2A63-4BC5-BB98-448F5E1CA04AQ24797305-153E67FB-CA2C-4AF5-9E87-589A3177E62FQ24800108-E85560DC-8C9D-407E-AA09-3A0FAE809088Q24806016-F883768D-6968-4501-B3C4-E7C8E337CB57Q24806182-E2BD78A7-84A3-420A-8382-BD011A2785DFQ24810733-D529944A-A04E-423E-9F52-310AB54F1685Q25257392-FBC2D12F-362D-4B0E-90B9-D38762DE16AAQ25257572-2AF037D3-3A96-42DB-9D14-F698F3A64776Q26799669-1C25D85D-6274-4510-A9E6-622E4F1EE286Q27008356-AC2C3CC8-16F1-4D00-8AAA-9B87388003EAQ27851709-F485830A-C861-4C68-8A75-8E765E25E1DDQ27860760-EAC6AD97-4650-4C7F-A0D6-0528FFBB644DQ28138778-7FAE8328-7591-4BAF-8982-940F4A10351FQ28138778-B7714143-9794-4896-9C67-2A2A98B1AD00Q28185257-FAC47A19-28C4-477D-AA55-955923310EB6Q28243330-EF97F210-E750-4060-8597-D7646CA9C1A6Q28260002-F4FF95B0-47FE-4F91-AF10-E8EF36C04295Q28267893-2FE54123-021A-4CAE-80E6-2E812CF70AEAQ28365024-35A96245-354F-4893-AAC9-CB66B8A846C1Q28388497-CA3CD678-5F9E-42ED-A6C3-84CD78E1DD84Q28584533-1EF4B45B-3494-4A70-A898-AB0BC3B81F8DQ29416989-1A379A48-8580-4549-923A-A9F27C15DCCAQ29417068-9C78612E-F8A1-4EF1-8D0D-9BE68FF20ADFQ29417084-C7CD20E7-A47E-4627-BAFC-5899329C5259Q29417145-05739957-A067-4B06-9D33-06333294BFEFQ29547841-EBA1C461-C1AE-4108-BA4B-BD40AA81BC83Q30000080-CA238D31-A3EC-4A8A-9A03-54E58A6DF9FDQ30275132-D5EB062E-9064-48A4-B1FE-E8F7F6F04DC0Q30275832-7D518F2E-EFC5-4EFA-895D-36DC0FE3CD26
P50
description
Australian scientist
@en
Australian scientist
@en-ca
Australian scientist
@en-gb
aŭstralia sciencisto
@eo
científica australiana
@es
eolaí Astrálach
@ga
geneticista australiana
@pt
genetista australiana
@ca
genetista australiana
@it
genetista australiarra
@eu
name
Georgia Chenevix-Trench
@ast
Georgia Chenevix-Trench
@ca
Georgia Chenevix-Trench
@en
Georgia Chenevix-Trench
@es
Georgia Chenevix-Trench
@fr
Georgia Chenevix-Trench
@ga
Georgia Chenevix-Trench
@sl
Georgia Chenevix-Trench
@sq
type
label
Georgia Chenevix-Trench
@ast
Georgia Chenevix-Trench
@ca
Georgia Chenevix-Trench
@en
Georgia Chenevix-Trench
@es
Georgia Chenevix-Trench
@fr
Georgia Chenevix-Trench
@ga
Georgia Chenevix-Trench
@sl
Georgia Chenevix-Trench
@sq
prefLabel
Georgia Chenevix-Trench
@ast
Georgia Chenevix-Trench
@ca
Georgia Chenevix-Trench
@en
Georgia Chenevix-Trench
@es
Georgia Chenevix-Trench
@fr
Georgia Chenevix-Trench
@ga
Georgia Chenevix-Trench
@sl
Georgia Chenevix-Trench
@sq
P106
P166
P19
P21
P27
P31
P4638
p3558.htm#i35574
P496
0000-0002-1878-2587
P569
1959-02-08T00:00:00Z